Our President & CEO, Mr. Hideaki Sato, will participate in a pitch event, “Hello Tomorrow Japan challenge 2022” as a speaker. 2022/09/09 Event Read
Notice of Reduction in the Amount of Share Capital and Disposal of Other Capital Surplus 2022/08/23 Notice Read
We will give a presentation at the 7th Annual Meeting of Nucleic Acids Therapeutics Society of Japan. 2022/07/30 Event Read
Our President & CEO, Mr. Hideaki Sato, will participate in a pitch event of “KPMG Tech Innovator Competition in Japan 2022” as a speaker. 2022/07/22 Event Read
Notice of exclusive license agreement for artificially modified nucleic acid technology with Takeda Pharmaceutical Company Limited 2022/02/24 Notice Read
Achieved milestonesbased on the technology license agreement with Aligos Therapeutics. 2021/12/10 Notice Read
We will exhibit at the 3rd PharmaLab EXPO Tokyo [Pharmaceuticals] R & D exhibition booth. 2021/12/06 Event Read
